VC-backed Veeva Systems adds to board of directors while two step down

By Iris Dorbian — 2 years ago

Veeva Systems, which is backed by Emergence Capital Partners, has appointed Paul Sekhri to its board of directors while Young Sohn and Kevin Spain have stepped down. Sekhri is senior vice president of integrated care at Sanofi. Based in Pleasanton, Calif., Veeva Systems is a provider of cloud-based software solutions for the global life sciences sector.


Sanofi Invests $125 Million in Warp Drive Bio

By Connie Loizos — 4 years ago

Boston-based Third Rock Ventures today launched the genomic search engine start-up, Warp Drive Bio, as part of a partnership with the French pharmaceutical company Sanofi. Sanofi is investing $125 million into the company, which Third Rock — an venture firm as well as incubator — has been developing for the last two years. PRESS RELEASE: […]


Sanofi-Aventis Buying Fovea Pharma for €370 Million

By PEHub Administrator — 6 years ago

Sanofi-Aventis has agreed to acquire Fovea Pharmaceuticals SA, a Paris, France-based drug company focused on ophthalmic diseases. The deal is valued at up to €370 million, including an upfront payment and possible milestone payments. Fovea had raised over $60 million in VC funding from firms like Forbion Capital Partners, Sofinnova Partners, Abingworth, GIMV, The Wellcome Trust and CAPE.


Sanofi Paying Up to $500 Million for BiPar Sciences

By PEHub Administrator — 7 years ago

Sanofi-aventis (NYSE: SNY) has agreed to acquire BiPar Sciences Inc., a Brisbane, Calif.-based developer of PARP inhibitors as cancer therapies. The deal could be worth up to $500 million, based on the achievement of milestones for BiPar’s lead candidate. BiPar has raised around $60 million in VC funding, from firms like Domain Associates, Canaan Partners, Vulcan Capital, PolyTechnos Venture-Partners, Asset Management Company and Quantum Technology Partners. It also has raised venture debt from Lighthouse Capital Partners.